Transforming growth factor β is sequestered into an inactive pool by lipoproteins

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2344-2352

  Grainger, David J ^a,b   Byrne, Christopher D ^a   Witchell, Christine M ^a   Metcalfe, James C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Cytokine; Diabetes; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOASSAY; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; CELL DIVISION; CELL LINE; CHOLESTEROL, LDL; CHROMATOGRAPHY, GEL; CHYLOMICRONS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; MINK; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030667088     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ross, R. 1993. The pathogenesis of atherosclerosis - a perspective for the 1990s. Nature. 362: 801-809.
2. Grainger, D. J., and J. C. Metcalfe. 1995. A pivotal role for TGF-β in atherogenesis? Biol. Rev. Camb. Philos. Soc. 70: 571-596.
3. Augustin, H. G., D. H. Kozian, and R. C. Johnson. 1994. Differentiation of endothelial cells - analysis of the constitutive and activated endothelial cell phenotypes. Bioessays. 16: 901-906.
4. Zheng, H., D. Fletcher, W. Kozak, M. H. Jiang, K. J. Hofmann, C. A. Conn, D. Soszynski, D., C. Grabiec, M. E. Trumbauer, A. Shaw, M. J. Kostura, K. Stevens, H. Rosen, R. J. North, H. Y. Chen, M. J. Tocci, M. J. Kluger, and L. H. T. Van Der Ploeg. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity. 3: 9-19.
5. Gamble, J. R., Y. Khew-Goodall, and M. A. Vadas. 1993. TGF-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150: 4494-4503.
6. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Y. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doestchnian. 1992. Targeted disruption of the mouse TGF-β1 gene results in multifocal inflammatory disease. Nature. 359: 693-699.
7. Wald, N. J., M. Law, H. C. Watt, T. S. Wu, A. Bailey, A. M. Johnson, W. Y. Craig, T. B. Ledue, and J. E. Haddow. 1994. Apolipoproteins and ischemic heart disease - implications for screening. Lancet. 343: 75-79.
8. Karpe, F., J. M. Bard, G. Steiner, L. A. Carlson, J. C. Fruchart, and A. Hamsten. 1993. HDLs and alimentary lipemia: studies in men with previous myocardial infarction at a young age. Arterioscler. Thromb. 13: 11-22.
9. Dunn, F. L. 1990. Hyperlipidemia in diabetes mellitus. Diabetes Metab. Rev. 6: 47-61.
10. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37: 1595-1607.
11. Byrne, C. D., N. J. Wareham, D. C. Brown, P. M. S. Clark, L. J. Cox, N. E. Day, C. R. Palmer, T. W. M. Wang, D. R. R. Williams, and C. N. Hales. 1994. Hypertriglyceridemia in subjects with normal and abnormal glucose tolerance - relative contributions of insulin secretion, insulin-resistance and suppression of plasma non-esterified fatty acids. Diabetologia. 37: 889-896.
12. Rapp, J. H., A. Lespine, R. L. Hamilton, N. Colyvas, A. H. Chaumeton, J. Tweedie-Hardman, L. Kotite, S. T. Kunitake, R. J. Havel, and J. P. Kane. 1994. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoproteinB immuno-adsorption from human atherosclerotic plaques. Arterioscler. Thromb. 14: 1767-1774.
13. Grainger, D. J., P. R. Kemp, J. C. Metcalfe, A. C. Liu, R. M. Lawn, N. R. Williams, A. A. Grace, P. M. Schofield, and A. Chauhan. 1995. The serum concentration of active TGF-β is severely depressed in advanced atherosclerosis. Nature Med. 1: 74-79.
14. Kanzaki, T., A. Olofsson, A. Moren, C. Wenstedt, U. Hellman, K. Miyazono, L. Claesson-Welch, and C. H. Heldin. 1990. TGF-β1 binding protein - a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell. 61: 1051-1061.
15. O'Connor-McCourt, M. D., and L. M. Wakefield. 1987. Latent transforming growth factor-β in serum - a specific complex with alpha-macroglobulin. J. Biol. Chem. 262: 14090-14099.
16. Harumiya, S., A. Omori, T. Sugiura, Y. Fukumoto, H. Tachikawa, and D. Fujimoto. 1995. EBP-37, a new elastin-binding protein in human plasma - structural similarity to ficolins, TGF-β1 binding-proteins. J. Biochem. 117: 1029-1035.
17. P. F. Edgar. 1995. Hucolin, a new corticosteroid-binding protein from human plasma with structural similarities to ficolins, TGF-β1 binding proteins. FEBS Lett. 375: 159-161.
18. Nunes, I., R. L. Shapiro, and D. B. Rifkin. 1995. Characterisation of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155: 1450-1459.
19. Nunes, I., P. E. Gleizes, C. N. Metz, and D. B. Rifkin. 1997. Latent TGF-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent TGF-β. J. Cell Biol. 136: 1151-1163.
20. Crookston, K. P., D. J. Webb, B. B. Wolf, and S. L. Gonias. 1994. Classification of α2-macroglobulin-cytokine interactions based on affinity of non-covalent association in solution under apparent equilibrium conditions. J. Biol. Chem. 269: 1533-1540.
21. Gonias, S. L., J. LaMarre, K. P. Crookston, D. J. Webb, B. B. Wolf, M. B. S. Lopes, H. L. Moses, and M. A. Hayes. 1994. α2-Macroglobulin and the α2-macroglobulin receptor LRP - a growth-regulatory axis. Ann. N.Y. Acad. Sci. 737: 273-290.
22. Sun, P. D., and D. R. Davies. 1905. The cysteine-knot growth factor superfamily. Annu. Rev. Biophys. Biomol. Struct. 24: 269-291.
23. Grainger, D. J., D. E. Mosedale, J. C. Metcalfe, P. L. Weissberg, and P. R. Kemp. 1995. Active and acid-activatable TGF-β in human sera, platelets and plasma. Clin. Chim. Acta. 235: 11-31.
24. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1352.
25. Grainger, D. J., C. M. Witchell, and J. C. Metcalfe. 1995. Tamoxifen elevates TGF-β and suppresses diet-induced formation of lipid lesions in mouse aorta. Nature Med. 1: 1067-1072.
26. Patsch, J. R. 1987. Post-prandial lipemia. In Bailliere's Clinical Endocrinology and Metabolism, J. Shepherd, editor. Balliere-Tindall. Vol. 1: 551-580.
27. Grainger, D. J., P. R. Kemp, A. C. Liu, R. M. Lawn, and J. C. Metcalfe. 1994. Activation of TGF-β is inhibited in transgenic apolipoprotein [a] mice. Nature. 370: 460-462.
28. Danielpour, D. D., L. L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn. 1989. Immunodetection and quantification of two forms of TGF-β (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell Physiol. 138: 79-86.
29. Yokode, M., R. E. Hammer, S. Ishibashi, M. S. Brown, and J. L. Goldstein. 1990. Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. Science. 250: 1273-1275.
30. Kirschenlohr, H. L. J. C. Metcalfe, P. L. Weissberg, and D. J. Grainger. 1993. Adult human aortic smooth muscle cells in culture produce active TGF-β. Am. J. Physiol. 265: C571-C576.
31. Syvanne, M. M. Ahola, S. Lahdenpera, J. Kahri, T. Kuusi, K. S. Virtanen, and M. R. Taskinen. 1995. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J. Lipid Res. 36: 573-582.
32. LaGrost, L., L. Persegol, C. Lallemant, and P. Gambert. 1994. Influence of apolipoprotein composition of high-density lipoprotein particles on cholesteryl ester transfer protein activity - particles containing various proportions of apolipoprotein A-I and apolipoprotein A-II. J. Biol. Chem. 269: 3189-3197.
33. Stampfer, M. J., F. M. Sacks, S. Salvini, W. C. Willett, and C. H. Hennekens. 1991. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N. Engl. J. Med. 325: 373-381.
34. Coresh, J., T. H. Beaty, V. L. Prenger, J. Xu, and P. O. Kwiterovich. 1995. Segregation analysis of HDL(3)-cholesterol levels in families of patients undergoing coronary arteriography at an early age. Arterioscler. Thromb. Vasc. Biol. 15: 1307-1313.
35. Smuts, C. M., H. F. H. Weich, M. J. Weight, M. Faber, M. Kruger, C. J. Lombard, and A. J. S. Benade. 1994. Free cholesterol concentrations in the high density lipoprotein subfraction-3 as a risk indicator in patients with angio-graphically documented coronary artery disease. Coron. Artery Dis. 5: 331-338.
36. Sweetnam, P. M., C. H. Bolton, J. W. G. Yarnell, D. Bainton, I. A. Baker, P. C. Elwood, and N. E. Miller. 1994. Associations of the HDL(2)-cholesterol and HDL(3)-cholesterol subfractions with development of ischemic heart disease in British men - the Caerphilly and Speed-well collaborative heart disease studies. Circulation. 90: 769-774.
37. Puchois, P., A. Kandoussi, P. Fievet, J. L. Fourrier, M. Bertrand, E. Koren, and J. C. Fruchart. 1987. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 68: 35-40.
38. Fruchart, J. C., and G. Ailhaud. 1992. Apolipoprotein A-containing lipoprotein particles - physiological role, quantification and clinical significance. Clin. Chem. 38: 793-797.
39. Genest, J. J. 1986. Plasma apolipoprotein[a], apolipoprotein A-I, apolipoprotein A-II, apolipoprotein B, apolipoprotein E, and apolipoprotein C-III-containing particles in men with premature coronary artery disease. Circulation. 82: 621 (abstr.).
40. Costeburel, M., F. Mainard, L. Chivot, J. L. Auget, and Y. Madec. 1990. Study of lipoprotein particles LpAI and LpAI/AII in patients before coronary bypass surgery. Clin. Chem. 36: 1889-1891.
41. Dupuy-Gorce, A. M., E. Desmarais, S. Vigneron, C. Buresi, V. Nicaud, A. Evans, G. Luc, D. Arveiler, P. Marques-Vidal, F. Cambien, L. Tiret, A. C. de Paulet, and G. Roizes. 1996. DNA polymorphisms in linkage disequilibrium at the 3′ end of the human APOAII gene: relationships with lipids apolipoproteins and coronary heart disease. Clin. Genet. 50: 191-198.
42. Elchebly, M., B. Porokhov, T. Pulcini, F. Berthezene, and G. Ponsin. 1996. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis. 123: 93-101.
43. Patsch, J. R., G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. K. Dunn, A. M. Gotto, and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease: studies in the post-prandial state. Arterioscler. Thromb. 12: 1336-1345.